GlassScriptPhysician profile
Ben J Tittle
NPI 1699851923
$73,115.51
in general payments reported to CMS, 2019-2025
17 companies · $2,716 in 2025
The $2,716 reported for 2025 was more than what 87% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50K · 2020: $9,501 · 2021: $5,894 · 2022: $732 · 2023: $1,058 · 2024: $3,207 · 2025: $2,716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,625 · Food and Beverage: $2,385 · Consulting Fee: $1,775 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,624.98 |
| Food and Beverage | $2,385.03 |
| Consulting Fee | $1,775.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $195.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $25,038.07 | 2019-2025 | Dysport |
| Merz North America, INC. | $18,768.98 | 2019-2022 | |
| Allergan, INC. | $12,291.93 | 2019-2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $9,702.44 | 2019-2022 | |
| Motiva USA, LLC | $2,344.14 | 2024-2025 | |
| Abbvie INC. | $2,204.49 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Musculoskeletal Transplant Foundation INC. | $1,510.78 | 2024-2025 | |
| Davol INC. | $389.22 | 2023-2025 | Arista Ah Flexitip |
| Sientra, INC. | $301.27 | 2021-2022 | |
| Stryker Corporation | $142.38 | 2019 | |
| Tela Bio, INC. | $136.67 | 2023-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Medical Device Business Services, INC. | $124.32 | 2025 | Dermabond |
| Pacira Pharmaceuticals Incorporated | $69.91 | 2019-2020 | |
| Sensus Healthcare, INC. | $43.48 | 2020 | |
| Innovation Technologies INC | $17.09 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $16.59 | 2019 | |
| Apyx Medical Corporation | $13.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ben Tittle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.